October 13, 2007 - Houston, Texas, USA
- One day, 20 speakers, 159 learners, no commercial exhibitors, no posters presented. There are 8 videos available on the biosymposia website for self-study (refer to online courses). The videos are also available in DVD format.
- Learner type: 58% Research Scientist, 35% Clinicians, and 7% Other.
- Credit type: ACCME, ANCC and ACPE.
- A unique group of basic and clinical oncologists presented cutting edge research. The faculty addressed topics including proteomics and genomics, targeted therapies, mouse models of brain tumorigenesis and cancer stem cells.
- 100% of learners reported that the content was free from commercial bias.
- 100% of learners reported that the content was scientifically rigorous.
- 100% of learners reported that they would recommend this program to a colleague.
- Objectives of the course were to:
- Identify biomarkers of brain tumors.
- Identify genes and proteins involved in brain tumorigenesis based on molecular profiling and functional experiments.
- Review current data from mouse model studies of brain tumors.
- Describe current targeted therapies for brain tumors.
- Understand the role of cancer stem cells in tumorigenesis.
- Selected learner comments included:
- “The speakers were very informative – the program was well-run and the schedule was adhered to.”
- “High quality talks.”
- “Good summary of cutting-edge research in neuro-oncology.”
- “Comprehensive coverage of one topic.”
- “Good amount of novel information.”
- “Superb quality of speakers, most interesting speakers.”
- “Interesting, nice spectrum of topics covered.”
- “More on pre-clinical data regarding therapeutics that are closer to clinical implementation.”
- “Have poster session.”
- Selected comments about the speakers included:
- “He was clear, concise and understandable to us non-MD/PhDs. Thank you.”
- “”Excellent to correlate traditional epidemiology with molecular study.”
- “Organized – excellent data.”
- “Interesting information on novel therapy.”
- "Well presented – eloquent speaker.”
- "Highly interesting and clear."
Disclosure of Faculty Relationships
BioSymposia, Inc. (formerly Serono Symposia International, Inc.) adheres to guidelines of the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center’s Commission on Accreditation (ANCCCA), the Accreditation Council for Pharmaceutical Education (ACPE), and all other professional organizations as applicable, stating that programs where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
As uses for pharmaceutical agents, medical devices, and other products may be presented in the program that are not necessarily the same as those indicated in approved product labeling (but which may reflect clinical experience, professional literature, other clinical sources known to the presenter, or investigational uses of products), we ask the presenter to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is simply intended to inform participants of any potential conflicts so that participants may form their own judgments based on full disclosure of the facts. Further, these opinions and recommendations presented during the program or materials related to the program do not imply an endorsement or recommendation on the part of BioSymposia, Inc. These presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-FDA approved (off-label) uses of drugs:
Ian F. Pollack, M.D. discloses that his presentation will include investigational studies of off-label or otherwise non-approved uses of products, and the CME content over which he has control contains information about healthcare products or services, although he does not have financial relationships within the past 12 months in connection with these healthcare products or services.
Howard Colman, M.D., Ph.D. discloses that the CME content over which he has control contains information about healthcare products or services (presentation contains pre-clinical/ in vitro data using chemotherapy agents, although no data regarding human preclinical trials will be presented), and that he has had a financial relationship within the past 12 months in connection with these healthcare products or services, namely as a consultant for Schering-Plough (Temozolomide Advisory Board meeting in July of 2006).
Charles G. Eberhart, M.D., Ph.D. discloses that within the past 12 months he has served as a consultant for Stemline Therapeutics and Genentech.
The following faculty indicated no significant relationship with commercial supporters and/or discussion of investigational or non-FDA approved (off-label) uses of drugs:
Oliver Bogler, Ph.D.; Ching Lau, M.D., Ph.D.; Ken Aldape, M.D.; Wadih Arap M.D., Ph.D.; Robert Bachoo, M.D., Ph.D.; Melissa Bondy, Ph.D.; Candelaria Gomez-Monzano, Ph.D.; Stephen Gottschalk, M.D.; David H. Gutmann, M.D., PhD.; Rebecca Holmes Johnson, M.D.; John Y. H. Kim, M.D., PhD.; Frederick F. Lang Jr., M.D.; Xiao-Nan Li, M.D., Ph.D.; Sadhan Majumder, Ph.D.; Stanley Nelson, Ph.D.; Renata Pasqualini, Ph.D.; Ganesh Rao, M.D.; Jack Su, M.D.; and Kwong-Kwok Wong, PhD.
Commercial Support and Other Disclosures
BioSymposia, Inc. (formerly Serono Symposia International, Inc.) is a 501(c)3 non-profit organization. All of our programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of BioSymposia, Inc.
This program was supported by an unrestricted educational grant from EMD Serono, Inc. In addition, BioSymposia personnel are employees of EMD Serono, Inc. and BioSymposia, Inc. also receives other in-kind support from EMD Serono, Inc. in the form of space and administrative services.
Printer friendly version Diagnosis and Therapeutic Discovery in Neuro-Oncology
